KINIKSA PHARMACEUTICALS-A (KNSA)
BMG5269C1010 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to KNSA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 28.82. This target is 70.4% above the current price.
KNSA was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KNSA.
In the previous month the buy percentage consensus was at a similar level.
KNSA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-02 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-07-26 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-03-09 | JP Morgan | Maintains | Overweight |
| 2021-12-29 | B of A Securities | Maintains | Buy |